CUSIP: G6461G106
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
61,493,568
-
Share change
-
+2,162,128
-
Total reported value
-
$469,195,000
-
Price per share
-
$7.63
-
Number of holders
-
30
-
Value change
-
+$16,496,579
-
Number of buys
-
17
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP G6461G106?
CUSIP G6461G106 identifies NFH - NEW FRONTIER HEALTH CORP - ORD SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP G6461G106:
Institutional Holders of NEW FRONTIER HEALTH CORP - ORD SHS (NFH) as of Q3 2020
As of 30 Sep 2020,
NEW FRONTIER HEALTH CORP - ORD SHS (NFH) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,493,568 shares.
The largest 10 holders included
Vivo Capital, LLC, Capital Research Global Investors, Fosun International Ltd, Aspex Management (HK) Ltd, MORGAN STANLEY, BAMCO INC /NY/, Capital International Investors, Yiheng Capital Management, L.P., York Capital Management Global Advisors, LLC, and Segantii Capital Management Ltd.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.